Alzheimer’s Breakthrough? Methylene Blue, Ketones & Light Therapy Explained
In this episode of Beyond Healthspan, Brandon and Dr. Richard LaFountain examine the work of neuroscientist Dr. Francisco Gonzalez-Lima, whose research proposes an alternative framework for understanding Alzheimer’s disease. Rather than focusing solely on amyloid plaques, his “vascular hypometabolism” model views the condition as a disorder rooted in impaired brain energy metabolism and mitochondrial dysfunction.
The discussion reviews evidence suggesting amyloid accumulation may be a secondary effect rather than the initiating event, and highlights the central role of cytochrome c oxidase in sustaining neuronal energy production. Brandon and Dr. LaFountain also explore potential interventions supported by Gonzalez-Lima’s findings, including methylene blue, ketone metabolism, and light therapy, and consider how these approaches may contribute to practical prevention and early intervention strategies.
Watch full episode: https://www.youtube.com/watch?v=vHuj0mSy-Yg